These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9694521)

  • 1. Acute tryptophan depletion attenuates the prolactin response to d-fenfluramine challenge in healthy human subjects.
    Coccaro EF; Kavoussi RJ; Cooper TB; Hauger R
    Psychopharmacology (Berl); 1998 Jul; 138(1):9-15. PubMed ID: 9694521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-HT3 receptor antagonism by ondansetron does not attenuate prolactin response to d-fenfluramine challenge in healthy human subjects.
    Coccaro EF; Kavoussi RJ; Cooper TB; Hauger R
    Psychopharmacology (Berl); 1996 Sep; 127(2):108-12. PubMed ID: 8888375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-HT2a/2c receptor blockade by amesergide fully attenuates prolactin response to d-fenfluramine challenge in physically healthy human subjects.
    Coccaro EF; Kavoussi RJ; Oakes M; Cooper TB; Hauger R
    Psychopharmacology (Berl); 1996 Jul; 126(1):24-30. PubMed ID: 8853213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral d-fenfluramine test in treatment-refractory depression. Plasma prolactin response compared in patients with and without suicide attempts and in a healthy reference group.
    Prochazka H; Sjögren M; Agren H
    J Affect Disord; 2000; 57(1-3):201-8. PubMed ID: 10708832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma tryptophan levels and prolactin response to fenfluramine in healthy volunteers.
    FitzGerald M; Malone K; Li S; Suckow R; Mann JJ
    Biol Psychiatry; 1997 Sep; 42(5):416-8. PubMed ID: 9276083
    [No Abstract]   [Full Text] [Related]  

  • 6. Neurohormonal responses to D-fenfluramine in healthy elderly subjects. A placebo-controlled study.
    Ramasubbu R; Flint A; Brown G; Awad G; Kennedy S
    Psychoneuroendocrinology; 2000 Feb; 25(2):139-50. PubMed ID: 10674278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diminished serotonin-mediated prolactin responses in nondepressed stroke patients compared with healthy normal subjects.
    Ramasubbu R; Flint A; Brown G; Awad G; Kennedy S
    Stroke; 1998 Jul; 29(7):1293-8. PubMed ID: 9660375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma oxytocin in response to pharmaco-challenge to D-fenfluramine and placebo in healthy men.
    Lee R; Garcia F; van de Kar LD; Hauger RD; Coccaro EF
    Psychiatry Res; 2003 May; 118(2):129-36. PubMed ID: 12798977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of pindolol on the prolactin response to d-fenfluramine.
    Park SB; Cowen PJ
    Psychopharmacology (Berl); 1995 Apr; 118(4):471-4. PubMed ID: 7568634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fenfluramine challenge, self-injurious behavior, and aggression in rhesus monkeys.
    Tiefenbacher S; Davenport MD; Novak MA; Pouliot AL; Meyer JS
    Physiol Behav; 2003 Nov; 80(2-3):327-31. PubMed ID: 14637232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of effect of hydrocortisone treatment on d-fenfluramine-mediated prolactin release.
    Young AH; Rue J; Odontiadis J; Cowen PJ
    Psychopharmacology (Berl); 1998 Mar; 136(2):198-200. PubMed ID: 9551777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormonal responses to d- and d,l-fenfluramine in healthy human subjects.
    Coccaro EF; Kavoussi RJ; Cooper TB; Hauger RL
    Neuropsychopharmacology; 1996 Dec; 15(6):595-607. PubMed ID: 8946434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seasonal variation in plasma prolactin response to D-fenfluramine in healthy subjects.
    Monteleone P; La Rocca A; Fuschino A; Bortolotti F; Maj M
    Psychoneuroendocrinology; 1999 Feb; 24(2):201-8. PubMed ID: 10101728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolactin hyperresponsiveness to D-fenfluramine in drug-free schizophrenic patients: a placebo-controlled study.
    Monteleone P; Tortorella A; Borriello R; Cassandro P; Maj M
    Biol Psychiatry; 1999 Jun; 45(12):1606-11. PubMed ID: 10376122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormonal responses to dl-fenfluramine challenge are not blunted in seasonal affective disorder.
    Yatham LN; Michalon M
    Psychoneuroendocrinology; 1995; 20(4):433-8. PubMed ID: 8532826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased tryptophan availability but normal post-synaptic 5-HT2c receptor sensitivity in chronic fatigue syndrome.
    Vassallo CM; Feldman E; Peto T; Castell L; Sharpley AL; Cowen PJ
    Psychol Med; 2001 May; 31(4):585-91. PubMed ID: 11352361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional consequences of central serotonin depletion produced by repeated fenfluramine administration in rats.
    Baumann MH; Ayestas MA; Rothman RB
    J Neurosci; 1998 Nov; 18(21):9069-77. PubMed ID: 9787010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolactin response to D-fenfluramine challenge test as a predictor of treatment response to haloperidol in acute schizophrenia.
    Mohr P; Horácek J; Motlová L; Libiger J; Czobor P
    Schizophr Res; 1998 Feb; 30(1):91-9. PubMed ID: 9542792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dieting decreases plasma tryptophan and increases the prolactin response to d-fenfluramine in women but not men.
    Walsh AE; Oldman AD; Franklin M; Fairburn CG; Cowen PJ
    J Affect Disord; 1995 Feb; 33(2):89-97. PubMed ID: 7759666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low prolactin response to fenfluramine in impulsive aggression.
    New AS; Trestman RF; Mitropoulou V; Goodman M; Koenigsberg HH; Silverman J; Siever LJ
    J Psychiatr Res; 2004; 38(3):223-30. PubMed ID: 15003426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.